ERSOT
NVO

Employees Retirement System of Texas’s Novo Nordisk NVO Stock Holding History

Employees Retirement System of Texas’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-72,964
Closed -$6.28M – 322
2024
Q4 		$6.28M Buy
72,964
+6,560
+10% +$709K 0.05% 150
2024
Q3 		$7.91M Buy
66,404
+8,890
+15% +$1.19M 0.07% 137
2024
Q2 		$8.21M Buy
57,514
+3,613
+7% +$479K 0.08% 129
2024
Q1 		$6.92M Buy
+53,901
New +$6.42M 0.08% 138
2022
Q3 		– Sell
-2,906
Closed -$162K – 580
2022
Q2 		$162K Hold
2,906
– – ﹤0.01% 696
2022
Q1 		$161K Hold
2,906
– – ﹤0.01% 736
2021
Q4 		$163K Buy
+2,906
New +$157K ﹤0.01% 742
2020
Q1 		– Sell
-180,000
Closed -$5.21M – 784
2019
Q4 		$5.21M Hold
180,000
– – 0.08% 293
2019
Q3 		$4.65M Buy
+180,000
New +$4.55M 0.07% 316

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Employees Retirement System of Texas's NVO Position: Q1 2025 in Review

Employees Retirement System of Texas sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 72,964 shares — an estimated $6.28M sold.

Employees Retirement System of Texas first reported a position in NVO in Q3 2019 and held it in 9 quarters. The position peaked at $8.21M in Q2 2024. 1,533 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Employees Retirement System of Texas reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Employees Retirement System of Texas sold 72,964 Novo Nordisk shares in Q1 2025, an estimated $6.28M.
  • Employees Retirement System of Texas first reported a position in Novo Nordisk in Q3 2019 and held it in 9 quarters.
  • Employees Retirement System of Texas's Novo Nordisk position peaked at $8.21M in Q2 2024.
  • 1,533 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Employees Retirement System of Texas's 13F filing for Q1 2025, filed 13 May 2025.